Clinical Trials In Vancouver

Discover hundreds of clinical trials in Vancouver.
Search clinical trials in Vancouver by condition or phase.

Filter

Filter results

Results: 682

Norovirus Research for Adults

Recruiting

Phase 3

Sponsor:

Moderna

Location:

Richmond, Seattle, Kelowna, Calgaryshow 151 more

Code:

NCT06592794

Conditions

Acute Gastroenteritis

Norovirus Acute Gastroenteritis

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Accepted

Interventions

mRNA-1403

Placebo

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Vancouver, Abbotsford, Tacoma, Kelownashow 114 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

Hypofractionated LocoRegional Radiotherapy in Breast Cancer

Recruiting

PHASE3

Sponsor:

Ontario Clinical Oncology Group (OCOG)

Location:

Vancouver, Victoria, Kelowna, Prince Georgeshow 13 more

Code:

NCT04228991

Conditions

Breast Neoplasms

Radiotherapy

Lymphedema

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Locoregional radiation treatment - Conventional fractionation

Locoregional radiation treatment - Hypofractionation

Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Recruiting

PHASE2

Sponsor:

University of British Columbia

Location:

Vancouver

Code:

NCT04234191

Conditions

Opioid Use Disorder

Eligibility Criteria

Sex: All

Age: 19+

Healthy Volunteers: Not accepted

Interventions

Buprenorphine/naloxone

Hydromorphone

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Recruiting

PHASE3

Sponsor:

Bellus Health Inc. - a GSK company

Location:

Bellingham, Kelowna, Portland, Calgaryshow 67 more

Code:

NCT05599191

Conditions

Refractory Chronic Cough

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BLU-5937

Placebo

Graded Exposure Therapy for Fear Avoidance Behaviour After Concussion

Recruiting

Sponsor:

University of British Columbia

Location:

Vancouver, Langley, Calgary, Toronto

Code:

NCT05365776

Conditions

Mild Traumatic Brain Injury

Eligibility Criteria

Sex: All

Age: 18 - 69

Healthy Volunteers: Not accepted

Interventions

Graded Exposure Therapy

Prescribed aerobic exercise

Enhanced usual care

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Recruiting

PHASE3

Sponsor:

Takeda

Location:

Surrey, Portland, Calgary, Red Deershow 86 more

Code:

NCT06550076

Conditions

Plaque Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAK-279

A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C

Recruiting

PHASE2

Sponsor:

BioWest Therapeutics Inc

Location:

Vancouver, Toronto

Code:

NCT00332176

Conditions

Chronic Hepatitis C

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Celgosivir

Peginterferon alfa 2b + ribavirin

Cerebral Palsy Hip Outcomes Project - International Multi-centre Study

Recruiting

Sponsor:

Holland Bloorview Kids Rehabilitation Hospital

Location:

Vancouver, Sacramento, Aurora, Saint Paulshow 7 more

Code:

NCT01987882

Conditions

Cerebral Palsy

Eligibility Criteria

Sex: All

Age: 2 - 18

Healthy Volunteers: Not accepted

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Recruiting

PHASE2

Sponsor:

Seagen Inc.

Location:

Vancouver, Seattle, Portland, Calgaryshow 33 more

Code:

NCT04879329

Conditions

Urothelial Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

disitamab vedotin

pembrolizumab

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Recruiting

PHASE2

Sponsor:

Theralase® Technologies Inc.

Location:

Vancouver, Madison, Chicago, San Antonioshow 8 more

Code:

NCT03945162

Conditions

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ruvidar® (TLD-1433) Bladder infusion and PDT